Literature DB >> 3597658

Quality of life of cancer patients at different stages in the disease trajectory.

J N Morris, S Sherwood.   

Abstract

Building on prior work with cancer patients, our analyses sought to determine whether the process of decline in quality of life identified for patients served by hospices applied to those in nursing homes; and to relate these findings to the broader community cancer population. We found the change in quality of life to be similar for terminal cancer patients in nursing homes and in the community. Findings from the broader spectrum of cancer patients in the community suggest that cancer patients tend to undergo serious reductions in life quality prior to the last 12 weeks of life, followed by another major loss during the last few weeks of life. Finally, we were unable to identify a sizable subgroup of cancer patients with positive quality of life scores in the period immediately preceding death. Further research is needed to specify the process of decline prior to the last few months during which diminution of life quality occurs.

Entities:  

Mesh:

Year:  1987        PMID: 3597658     DOI: 10.1016/0021-9681(87)90012-9

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  12 in total

Review 1.  Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer.

Authors:  H M Bryson; G L Plosker
Journal:  Pharmacoeconomics       Date:  1993-07       Impact factor: 4.981

Review 2.  Critical review of the international assessments of health-related quality of life.

Authors:  R T Anderson; N K Aaronson; D Wilkin
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

3.  Symptom profiles and palliative care in advanced pancreatic cancer: a prospective study.

Authors:  Knut Jørgen Labori; Marianne Jensen Hjermstad; Torunn Wester; Trond Buanes; Jon Håvard Loge
Journal:  Support Care Cancer       Date:  2006-04-07       Impact factor: 3.603

4.  The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life.

Authors:  N Tjarda Van Heek; Steve M M De Castro; Casper H van Eijck; Rutger C I van Geenen; Eric J Hesselink; Paul J Breslau; T C Khe Tran; Geert Kazemier; Mechteld R M Visser; Olivier R C Busch; Hugo Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

5.  Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers.

Authors:  Eva Grunfeld; Doug Coyle; Timothy Whelan; Jennifer Clinch; Leonard Reyno; Craig C Earle; Andrew Willan; Raymond Viola; Marjorie Coristine; Teresa Janz; Robert Glossop
Journal:  CMAJ       Date:  2004-06-08       Impact factor: 8.262

6.  Randomised controlled trial of effects of coordinating care for terminally ill cancer patients.

Authors:  J M Addington-Hall; L D MacDonald; H R Anderson; J Chamberlain; P Freeling; J M Bland; J Raftery
Journal:  BMJ       Date:  1992-11-28

7.  Assessing the needs and quality of life of patients with HIV infection: development of the HIV Overview of Problems-Evaluation System (HOPES).

Authors:  C A Schag; P A Ganz; B Kahn; L Petersen
Journal:  Qual Life Res       Date:  1992-12       Impact factor: 4.147

8.  Measuring quality of life in hospice patients using a newly developed Hospice Quality of Life Index.

Authors:  S C McMillan; M Mahon
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

9.  Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care?

Authors:  J M Addington-Hall; L D MacDonald; H R Anderson
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

10.  Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Palliative care (FACIT-Pal) scale.

Authors:  Kathleen Doyle Lyons; Marie Bakitas; Mark T Hegel; Brett Hanscom; Jay Hull; Tim A Ahles
Journal:  J Pain Symptom Manage       Date:  2008-05-27       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.